Trial
NCT03678090
The Safety and Efficacy of Fibrinolysis in Patients With an Indwelling Pleural Catheter for Multi-loculated Malignant Pleural Effusion.
Phase IIWITHDRAWNREGULATORYConfidence: MEDIUM
Sponsor
Yale University
Collaborators
—
Condition
Pleural Effusion
Intervention
tPA standard dosage
Why stopped
Local IRB recommended IND exemption from FDA, study timeline not able to be met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-05